Hims & Hers HealthHIMS +3.76%81 OCF Yield % is 3.57 as of Jun. 27, 2026, which is 98% above its 10-year median of 1.80. GuruFocus rates HIMS with a GF Score™ of 81/100 and a GF Value™ of $38.70 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Hims & Hers Health ranks better than 50.45% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hims & Hers Health OCF Yield % Related Terms
Hims & Hers Health OCF Yield % Historical Data
* Premium members only.
The historical data trend for Hims & Hers Health's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hims & Hers Health OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Hims & Hers Health's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (HIMS) has a OCF Yield % of 3.57 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hims & Hers Health and its competitors. This is 98% above median its historical median of 1.80. According to the industry distribution chart, Hims & Hers Health ranks #498 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 49.6%.
Is Hims & Hers Health's OCF Yield % too high?
Hims & Hers Health's current OCF Yield % of 3.57 is 98% above median its 10-year median of 1.80. The Drug Manufacturers industry median OCF Yield % is 3.61. Hims & Hers Health's value of 3.57 is 1.1% below this industry median. Based on the distribution chart, Hims & Hers Health ranks #498 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hims & Hers Health has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's OCF Yield % compare to LNTH and LQDA?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #498 out of 1005 companies for OCF Yield %. This puts Hims & Hers Health in the upper half of its industry. The industry median OCF Yield % is 3.61. Hims & Hers Health's value of 3.57 is 1.1% below this benchmark. While the company's 10-year median is 1.80 vs. the industry median of 3.61, Hims & Hers Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hims & Hers Health's current OCF Yield % of 3.57 is 1.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hims & Hers Health and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hims & Hers Health's current OCF Yield % is 3.57, which is 98% above median its own 10-year median of 1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is $38.70, compared to a current price of $33.94 — trading 12.3% below its estimated fair value. The current OCF Yield % is 3.57, which is 98% above median its 10-year median of 1.80 and 1.1% below the Drug Manufacturers industry median of 3.61. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current OCF Yield % is 3.57 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of $33.94 is trading 12.3% below its estimated GF Value™ of $38.70.
GuruFocus considers Hims & Hers Health to be Modestly Undervalued.
Key valuation signals for HIMS:
OCF Yield %: 3.57 (98% above median its 10-year median of 1.80)
GF Value™: $38.70 vs. price of $33.94 (12.3% below fair value)
Industry Position: 1.1% below the Drug Manufacturers median (#498 of 1005)
No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score
Get the complete analysis for HIMS
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HIMS has been successfully added to your 
